Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Nov 27, 2024; 16(11): 3484-3498
Published online Nov 27, 2024. doi: 10.4240/wjgs.v16.i11.3484
Table 1 Analysis of data related to gastric cancer patients, n (%)
Characteristics
Total (n = 120)
Characteristics
Total (n = 120)
Age (years) 64 (54.25, 71)Surgical method
Open 33 (27.5)
Laparoscope87 (72.5)
GenderRange of excision
    MaleDistal53 (44.2)
    Female80 (66.7) Proximal21 (17.5)
Total46 (38.3)
40 (33.3)
BMI (kg/m2)22.79 (20.22, 20.38)Operation time (min)280 (225, 339)
DiabetesAnesthesia duration (min) 325 (271.25, 390)
    Yes11 (9.2)
    No109 (90.8)
AnemiaRTBS (h) 20.4 (15.2, 25.775)
    Yes44 (36.7)
    No76 (63.3)
HypoproteinemiaNBS (cpm) 1.95 (0.89, 3.06)
    Yes22 (18.3)
    No98 (81.7)
Tumor siteBSVA (dB) 47.179 (44.75, 49.28)
    Cardiac21 (17.5)
    Body63 (52.5)
    Antrum36 (30.0)
4
Tumor size(3.00, 5.00) FBS (Hz) 424.32 (383.45, 485.76)
Stage cTNM
    017 (14.2)
    I20 (16.7)
    II32 (26.7)
    III41 (34.2)
    IV8 (3.3)
Table 2 Characteristics of patients in the training, internal validation and external validation groups, n (%)
Variable
Overall (N = 120)
Training (N = 84)
Validation (N = 36)
P value
Age (years) 0.291
    ≥ 7040 (33.3) 25 (29.8) 15 (41.7)
    < 7080 (66.7) 59 (70.2) 21 (58.3)
Gender0.291
    Male80 (66.7) 59 (70.2) 21 (58.3)
    Female40 (33.3) 25 (29.8) 15 (41.7)
BMI (kg/m2)0.768
    < 18.516 (13.3) 10 (16.7) 6 (8.3)
    > 18.8 < 2582 (68.3) 58 (18.1) 24 (18.8)
    > 2522 (18.4) 16 (65.3) 6 (72.9)
Smoking0.078
    Yes46 (38.3) 37 (40.0) 9 (25)
    No74 (61.7) 47 (60.0) 27 (75)
Drinking0.345
    Yes21 (17.5) 17 (20.2) 4 (11.1)
    No99 (82.5) 67 (79.8) 32 (88.9)
Hypertension0.05
    Yes33 (27.5) 28 (33.3) 5 (13.9)
    No87 (72.5) 56 (66.7) 31 (86.1)
Diabetes0.581
    Yes11 (9.2) 9 (10.7) 2 (5.6)
    No109 (90.8) 75 (89.3) 34 (94.4)
Previous abdominal surgery0.885
    Yes26 (21.7) 19 (22.6) 7 (19.4)
    No94 (78.3) 65 (77.4) 29 (80.6)
Anemia1
    Yes44 (36.7) 31 (36.9) 13 (36.1)
    No76 (63.3) 53 (63.1) 23 (63.9)
Hypoproteinemia0.135
    Yes22 (18.3) 12 (14.3) 10 (16.8)
    No98 (81.7) 72 (85.7) 26 (72.2)
Preoperative potassium1
    Normal108 (90.0) 76 (90.5) 32 (88.9)
    Abnormal 12 (10.0) 8 (9.5) 4 (11.1)
Emergency surgery0.444
    Yes3 (2.5) 1 (1.2) 2 (5.6)
    No117 (97.5) 83 (98.8) 34 (94.4)
Preoperative bowel preparation0.784
    Yes114 (95.0) 79 (94.0) 35 (97.2)
    No6 (5.0) 5 (6.0) 1 (2.8)
Tumor size (cm) 0.693
    < 576 (63.3) 52 (61.9) 24 (66.7)
    ≥ 5 < 1036 (30.0) 27 (32.1) 9 (25.0)
    ≥ 108 (6.7) 5 (6.0) 3 (8.3)
Tumor site0.627
    Cardiac21 (17.5) 13 (15.5) 8 (22.2)
    Body63 (52.5) 46 (54.8) 17 (47.2)
    Antrum36 (30.0) 25 (29.8) 11 (30.6)
Stage cTNM0.537
    017 (14.2) 11 (13.1) 6 (16.7)
    I20 (16.7) 13 (15.5) 7 (19.4)
    II32 (26.7) 25 (29.8) 7 (19.4)
    III43 (35.8) 28 (33.3) 15 (41.7)
    IV8 (6.7) 7 (8.3) 1 (2.8)
Surgical method0.858
    Open33 (27.5) 24 (28.6) 9 (25)
    Laparoscope87 (72.5) 60 (71.4) 27 (75)
Range_of_excision0.427
    Distal21 (17.5) 17 (20.2) 4 (11.1)
    Proximal53 (44.2) 37 (44.0) 16 (44.4)
    Total46 (38.3) 30 (35.7) 16 (44.4)
Operation time (min)1
    < 27563 (52.5) 44 (52.4) 19 (52.8)
    ≥ 27557 (47.5) 40 (47.6) 17 (47.2)
Anesthesia time (min) 0.803
    < 36543 (35.8) 29 (34.5) 14 (38.9)
    ≥ 36577 (64.2) 55 (65.5) 22 (61.1)
RTBS (h) 0.144
    < 1592 (76.7) 68 (81.0) 24 (66.7)
    ≥ 1528 (23.3) 16 (19.0) 12 (33.3)
NBS (cpm) 1
    ≥ 2.43648 (40.0) 34 (40.5) 14 (38.9)
    < 2.43672 (60.0) 50 (59.5) 22 (61.1)
BSVA (dB) 0.964
    < 44.79388 (73.3) 61 (72.6) 27 (75.0)
    ≥ 44.79332 (26.7) 23 (27.4) 9 (25.0)
FBS (Hz) 1
    < 461.56036 (30.0) 25 (29.8) 11 (30.6)
    ≥ 461.56084 (70.0) 59 (70.2) 25 (69.4)
Table 3 Association of prolonged postoperative ileus with background and operative variables in bivariate analysis and in multivariable models
s
Variable
PPOI number (%)
P value
Multivariable OR (95CI)
P value
Age0.009
    ≥ 7011/25 (44) < 0.0015.779
    < 7012/59 (56) (1.620-23.84)
Gender
    Male15/59 (25.4) 0.386
    Female8/25 (32.0)
BMI
    < 18.54/10 (40.0) -
    ≥ 18.8 < 2516/58 (27.5) 0.181
    ≥ 253/16 (18.8) 0.094
Smoking0.267
    Yes7/37 (18.9)
    No16/47 (34.0)
Drinking0.235
    Yes6/17 (35.3)
    No17/67 (25.3)
Hypertension0.972
    Yes7/28 (25.0)
    No16/56 (28.6)
Diabetes0.182 
    Yes1/9 (11.1)
    No22/75 (29.3)
Previous abdominal surgery0.36
    Yes8/19 (42.1)
    No15/65 (23.1)
Anemia0.702
    Yes8/31 (25.8)
    No15/53 (28.3)
Hypoproteinemia< 0.00115.0 (3.44-87.19) < 0.001
    Yes7/28 (25.0)
    No16/56 (28.6)
Preoperative potassium0.634
    Normal21/76 (27.6)
    Abnormal2/8 (25.0)
Emergency surgery0.819
    Yes0/1 (0.0)
    No23/83 (27.1)
Tumor size (cm)
    < 512/52 (23.1) -
    ≥ 5 < 108/27 (29.6) 0.535
    ≥ 103/5 (60.0) 0.449
Tumor site
    Cardiac 3/13 (23.1) -
    Body14/46 (30.4) 1
    Antrum6/25 (24.0) 0.767
Stage cTNM
    00/11 (0.0) --
    I5/13 (38.5) 0.09119.64 (1.57-646.93) 0.042
    II6/25 (24.0) 0.0965.46 (0.49-149.62) 0.216
    III8/28 (28.6) 0.0739.71 (0.99-256.35) 0.089
    IV4/7 (57.1) 0.02698.8 (4.55-4617.35) 0.006
RTBS0.0120.15 (0.03-0.59) 0.001
    ≥ 157/16 (43.8)
    < 1516/68 (23.5)
NBS (cpm) 0.0010.077 (0.01-0.33) 0.001
    ≥ 2.43618/64 (28.1)
    < 2.4365/20 (25.0)
BSVA (dB) 0.2
    ≥ 44.7935/23 (21.7)
    < 44.79318/61 (29.5)
FBS (Hz) 0.0078.81 (2.35-10.91)0.002
    ≥ 461.56012/59 (20.3)
    < 461.56011/25 (44.0)